PCSK9 and type 1 diabetes mellitus: Concerning atherogenic dyslipidemia, the association between PCSK9 concentration and elevated TG levels or the prevalence of small dense LDL (sdLDL) has already been described in previous studies25,27,41,42 in patients with T1D and type 2 diabetes25,27,41,42.